BFI Co., LLC 4
4 · PHIBRO ANIMAL HEALTH CORP · Filed Aug 23, 2018
Insider Transaction Report
Form 4
BFI Co., LLC
10% Owner
Transactions
- Conversion
Class A Common Stock
2018-08-21+30,000→ 60,000 total - Sale
Class A Common Stock
2018-08-21$50.35/sh−10,000$503,500→ 50,000 total - Conversion
Class B Common Stock
2018-08-21−30,000→ 20,216,034 totalExercise: $0.00→ Class A Common Stock (30,000 underlying) - Sale
Class A Common Stock
2018-08-22$49.92/sh−10,000$499,200→ 40,000 total - Sale
Class A Common Stock
2018-08-23$49.84/sh−10,000$498,400→ 30,000 total
Footnotes (5)
- [F1]Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.90 to $50.65, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.75 to $50.65, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.70 to $50.10, inclusive.